Contract 1. Active and placebo capsule manufacture for the LAMDARCT Clinical Trial
This contract will not be signed.
Date of decision not to sign contract
5 December 2025
Reason for not signing contract
Start date, value and scope have changed, a UK5 and UK6 will be published for a new procurement.
Supplier
Contract value
- £416,789.25 excluding VAT
- £500,147.10 including VAT
Contract dates
- 1 November 2025 to 1 November 2029
- 4 years, 1 day
Supplier
ALMAC CLINICAL SERVICES LIMITED
- Companies House: NI041905
- Public Procurement Organisation Number: PRCD-2287-GMQG
Almac House
Craigavon
BT63 5QD
United Kingdom
Email: csrfinotifcations@almacgroup.com
Website: http://ww.almacgroup.com
Region: UKN07 - Armagh City, Banbridge and Craigavon
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. Active and placebo capsule manufacture for the LAMDARCT Clinical Trial
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland